Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunosurveillance‑guided timing of antifungal prophylaxis in hematologic tumors
ChiCTR2400079810Phase 4Recruiting
- Sponsor
- Huadong Hospital, Fudan University
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluconazole in invasive mycoses (3 arms), sponsored by Huadong Hospital, Fudan University. Primary endpoints: Immunoglobulin level and Incidence of invasive fungal infections. Started Jan 2024; status: recruiting.
02
Drugs
fluconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on ChiCTR2400079810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079810.